GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

RemeGen Co 9995.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

70.40

+0.28%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About RemeGen Co

Its shares trade on HKEX under the ticker 9995.HK. It has been listed since 9 November 2020. In the fiscal year to 31 December 2025, it reported revenue of CN¥3.76bn and net income of CN¥818.8m. At that date it held total assets of CN¥8.38bn and shareholders' equity of CN¥2.68bn.

RemeGen Co., Ltd. is a biopharmaceutical company. The company is headquartered in Yantai, Shandong. The company went IPO on 2020-11-09. The firm's clinical-stage drug candidates include telitacicept (RC18) used for the treatment of systemic lupus erythematosus, and disitamab vedotin (RC48) used for the treatment of gastric cancer.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
9 Nov 2020
Employees
1,259
Website
remegen.cn ↗

Leadership

Pay as last reported

  • Mr. Weidong WangExecutive Chairman of the Board, since 2013CN¥2.5m
  • Mr. Jianmin FangChief Executive Officer, Chief Scientific Officer, General Manager, Executive Director, since 2008CN¥7.4m
  • Mr. Shaojing TongChief Financial Officer, Joint Company SecretaryCN¥4.3m
  • Mr. Qingkai WenExecutive Director, Secretary of the Board, since 2020CN¥2.3m
  • Mr. Jian LinExecutive Director, since 2008CN¥809,400
  • Ms. Xiaodi SuNon-Executive Director
  • Mr. Liqiang WangNon-Executive Director
  • Mr. Yunjin ChenIndependent DirectorCN¥300,000
  • Mr. Xianjing HaoIndependent DirectorCN¥300,000
  • Mr. Guobin HuangIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
69
Environment
62
Social
65
Governance
79
Direct emissions (scope 1)
54.15 t
Energy emissions (scope 2)
59,099.23 t
Women in the workforce
54.01137%
Carbon reduction policy
No
Human rights policy
Yes

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.